Syncona focuses short-term cash on more conservative investments

Healthcare firm Syncona plans to focus its investment strategy more towards conservative investments like cash and bonds moving forward.

Syncona will be simplifying its investment parameters, directing its capital pool on liquidity and capital preservation in order to support its strategy of funding life science companies.

The FTSE 250-listed outfit plans to significantly reduce its fund investments and further increasing its weighting to cash, cash equivalents and fixed income products with higher liquidity and lower volatility over the next three to six months.

Chief executive Martin Murphy said: "This is a natural next step for the management of our capital pool. Our life science portfolio has generated significant value to date, with the offer for Nightstar demonstrating our ability to deliver strong returns.

"Successful life science companies scale rapidly, and our existing portfolio is now at the stage where our strategic capital pool ideally positions Syncona to capitalise on the commercial opportunities ahead of us."

As of 0820 GMT, Syncona shares had sipped 0.76% to 260.50p.